![](/img/cover-not-exists.png)
Dual Inhibition of the Epidermal Growth Factor Receptor with Cetuximab, an IgG1 Monoclonal Antibody, and Gefitinib, A Tyrosine Kinase Inhibitor, in Patients with Refractory Non-small Cell Lung Cancer (NSCLC): A Phase I Study
Ramalingam, Suresh, Forster, Judy, Naret, Cynthia, Evans, Terry, Sulecki, Matt, Lu, Haolan, Teegarden, Paola, Weber, Martin R., Belani, Chandra P.Volume:
3
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e3181653d1b
Date:
March, 2008
File:
PDF, 103 KB
english, 2008